Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese deaths prompt Osteobond recall:

This article was originally published in Clinica

Executive Summary

Zimmer has recalled its bone adhesive Osteobond from Japan, following reports linking three deaths from sudden hypotension and cardiac arrest. The copolymer cement - a mixture of monomeric and polymeric methyl methacrylate with barium sulphate - was launched by the Bristol-Myers Squibb subsidiary in Japan in April, and has been used for joint replacements in 1800 patients since then. The company is claiming confidence in the product and says the recall is a safety measure.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086888

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel